INO - Inovio Pharmaceuticals - A NYSE Small-Cap Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : INO - Inovio Pharmaceuticals - A NYSE Small-Cap

INO 2.250

+4.7%

Dec 24 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Lynn who wrote (47)	6/21/2018 10:08:47 AM
From: donpat	Read Replies (1) of 67

"The lowdown is that analysts think that VGX-3100 can generate a healthy $622 million in sales by 2024" Impressive. Get in now...never get out!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next